CaNCURE is a partnership between Northeastern University and
Dana-Farber / Harvard Cancer Center funded by the National Cancer Institute.

In Vivo Imaging Guides Prediction and Optimization of Nanomedicine Action in Cancer

Friday, October 20, 2017 3:25 PM

posted in: Joint CaNCURE and Nanomedicine Academy Seminar

Dr. Miles Miller Assistant Professor of Radiology, MGH Drug-loaded therapeutic nanoparticles have been developed to deliver drugs more safely and effectively to tumors.  In principle, the “enhanced permeability and retention” (EPR) effect operates to improve selective tumoral nanomedicine delivery via features including hyper-permeable tumor vasculature and dysfunctional lymphatics; however, in practice, EPR effects are often […]

Blood trails: nanotechnology-enabled biomarker quantification for early disease detection

Friday, October 13, 2017 3:25 PM

posted in: Joint CaNCURE and Nanomedicine Academy Seminar

Dr. Tony Hu’s research focuses on developing and validating integrated nanotechnique-based strategies for marker discovery and molecular diagnostics in peripheral blood samples to provide a translatable solution for personalized medicine. His innovations aim to fill current gaps in early detection, real-time therapy monitoring and effective prognostics. Instead of competing on lowering the detection limit of […]

© 2014 CaNCURE